Bharat Biotech 保证 Covaxin 的安全性。 Bharat Biotech assures safety of Covaxin.

印度疫苗制造商 Bharat Biotech 是 Covaxin 的开发商，在有报道称阿斯利康的新冠疫苗出现罕见副作用后，该公司强调其对安全性的关注。 Indian vaccine maker Bharat Biotech, developer of Covaxin, asserts its focus on safety amid reports of rare side effects from AstraZeneca's COVID-19 vaccine. Covaxin 是印度免疫计划中唯一的疫苗，具有出色的安全记录，Bharat Biotech 强调其致力于优先考虑所有疫苗的安全性。 Covaxin, the only Indian vaccine in the country's immunization program, has demonstrated an excellent safety record, and Bharat Biotech emphasizes its commitment to prioritizing safety in all its vaccines. 尚未有与 Covaxin 疫苗相关的事件报告。 No reports of vaccine-associated incidents have been reported with Covaxin.

文章

Devdiscourse

Times of India

Livemint

-- 显示更少 --

延伸阅读

相关故事